The enzymatic activity of 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase is enhanced by NPM-ALK: new insights in ALK-mediated pathogenesis and the treatment of ALCL
Francesco Boccalatte(NYU Langone Health), Giorgio Inghirami(New York University)
Cited by 52
Related Papers
NPM-ALK transgenic mice spontaneously develop T-cell lymphomas and plasma cell tumors
|Blood|2003|247
Functional validation of the anaplastic lymphoma kinase signature identifies CEBPB and Bcl2A1 as critical target genes
|Journal of Clinical Investigation|2006|164
Ablation of oncogenic ALK is a viable therapeutic approach for anaplastic large-cell lymphomas
|Blood|2005|128